$33.88 Bn Glucose Monitoring Market - Global Forecast to 2029 - Increasing Demand for Minimally or Non-Invasive and Point-Of-Care Devices Bodes well for the Sector - ResearchAndMarkets.com
08 Jun 2023
DUBLIN--(BUSINESS WIRE)--The "Glucose Monitoring Global Market - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
'Glucose Monitoring Global Market - Forecast to 2029'
Glucose monitoring global market is expected to grow at a double digit CAGR from 2022 to 2029 reach $33,886.4 million by 2029.
Factors driving the Glucose Monitoring market are the global rise in the prevalence of diabetes, increasing demand for a less minimally invasive or non-invasive and point-of-care device; increasing R&D investments are driving the market growth, whereas, the growing diffusion of smart devices and digital platforms increasing compliance and management of diabetes is creating opportunities in the coming years.
The high cost of the products, frequent product recalls and inadequate reimbursement is restraining the market growth. The stringent regulations for product approval, privacy concerns and safety issues are threats for the market growth.
The products market is divided into three segments, namely, Invasive, non-Invasive and lab-based glucose monitoring products. Among them, the Invasive glucose monitoring products segment accounted for the largest share in 2022 and is projected to grow at a double digit CAGR from 2022 to 2029 due to technological advancements, easy use, and patient-friendly nature of products. The non-invasive glucose monitoring segment is projected to grow at mid single digit CAGR from 2022 to 2029.
The Invasive glucose monitoring products are further segmented into self-monitoring blood glucose (SMBG) and continuous glucose monitoring (CGM) products, among them, the continuous glucose monitoring segment accounted for the largest share in 2022 and is expected to grow at high teen CAGR from 2022 to 2029 due to increasing awareness among patients and introduction of connected devices for integrated health management.
The continuous glucose monitoring market is further sub-segmented into sensors and receivers & transmitters, among which, the sensors segment is the fastest-growing segment and is projected to grow at high single CAGR from 2022 to 2029. The Self glucose monitoring products are further sub-segmented into blood glucose monitors, blood glucose test strips, and lancets & others.
Based on sample source the market is segmented into blood, urine and others. The blood segment accounted for the largest share in 2022 and is projected to grow at double digit CAGR from 2022 to 2029 due to the high accuracy of results. Other source-based glucose monitoring segment is the fastest-growing segment and is projected to grow at a strong double digit CAGR from 2022 to 2029 due to increased R&D investment, many products getting regulatory approved and ready to launch products.
Based on end-users the market is segmented into hospitals, private clinics, home care and ambulatory settings, among them, the home care segment accounted for the largest share in 2022 and is projected to grow at early teen CAGR from 2022 to 2029 due to the availability of over the counter (OTC) self blood glucose monitor and ease in operating these monitors and thereby reducing the frequent visits to hospitals or clinics for checking glucose levels.
North America accounts for the largest market share in 2022 and the market is projected to grow at double digit CAGR from 2022 to 2029. The European market is the fastest growing region with early teen CAGR from 2022 to 2029 due to a steep rise in the aging population, advancement in technology, awareness of people about treatment options and favorable government policies.
The Asia-Pacific market is projected to grow at double digit CAGR from 2022 to 2029, while the RoW region is projected to grow at high single digit CAGR from 2022 to 2029.
Major players in the Glucose monitoring market include
Abbott Laboratories (U.S.)
Dexcom (U.S.)
Roche (Switzerland)
LifeScan (U.S.)
Medtronic, Inc. (Ireland)
PHC Holding (Ascensia) (Japan)
Sinocare (China)
Arkray (Japan)
Bio-Rad Laboratories (U.S.)
i-Sens, Inc., (South Korea)
Key Topics Covered:
Factors Influencing Market
Drivers and Opportunities
The Global Rise in the Prevalence of Diabetes
Increasing Demand for Minimally or Non-Invasive and Point-Of-Care Devices.
Increasing R & D Investments
Growing Diffusion of Smart Devices and Digital Platforms Increasing Compliance and Management of Diabetes
Restraints and Threats
High Cost Associated With the Products
Inadequate Reimbursement
Product Recalls
Strict Regulation of Glucose Monitoring Devices by Regulatory Organizations Like the Fda and Others
Privacy Concern and Safety Issues in Connected Devices
Regulatory Affairs
U.S.
Europe
China
India
Japan
Reimbursement Scenario
Patent Analysis
Technology Advancements
Non-Invasive Glucose Monitoring Technologies
Optical Glucose Monitoring
Breath Glucose Monitoring
Sweat Glucose Monitoring
Pipeline of Non-Invasive Glucose Monitoring Devices
Funding Scenario
Porter's Five Force Analysis
Market Share Analysis by Major Players
Glucose Monitoring Global Market Share Analysis
Self Blood Glucose Monitoring Global Market Share Analysis
Continuous Glucose Monitoring Global Market Share Analysis
Regional Market Share Analysis
Units Sold
Glucose Testing Strips Units Sold
Number of Cgm Sensors Sold
Market Penetration Analysis
A selection of companies featured in the report
77 Elektronika KFT
Abronn fze
Ailex Technology Group Co., Ltd
Alliance International Co. Ltd
Allmedicus Co., Ltd
Andesfit System Limited
Beurer Gmbh
BioTelemetry (Philips)
Bremed Limited
Cambridge Sensors Ltd (Microdot)
CEI Technology, Inc
Dario Health Corp.
Delbio, Inc.
Dr. Morepen
Drive DeVilbiss Healthcare
EasyMax Diabetes Care
e-LinkCare Meditech Co., Ltd.
Hannox International
i-Sens
Keto-Mojo Europe B.V.
Life Scan, Inc.
Lifotronic Technology Co., Ltd
Lobeck Medical AG
L-Tac MediCare Pte Ltd.
Microlife AG
nu-beca & maxcellent Co.
Occuity
Palmdoc, Ltd
Paramedical srl
Pharma Tech Solutions, Inc.
SD Biosensor. Inc.
Visgeneer
VivaChek Biotech (Hangzhou) Co., Ltd
Volta S.r.l.
For more information about this report visit https://www.researchandmarkets.com/r/4049di
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.